Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Share-based Compensation (2016 - 2025)

Arcadia Biosciences' Share-based Compensation history spans 12 years, with the latest figure at $17000.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 85.47% year-over-year to $17000.0; the TTM value through Dec 2025 reached $234000.0, down 54.3%, while the annual FY2025 figure was $234000.0, 54.3% down from the prior year.
  • Share-based Compensation reached $17000.0 in Q4 2025 per RKDA's latest filing, down from $53000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $465000.0 in Q4 2021 to a low of $17000.0 in Q4 2025.
  • Average Share-based Compensation over 5 years is $203150.0, with a median of $180500.0 recorded in 2023.
  • Peak YoY movement for Share-based Compensation: skyrocketed 92.15% in 2021, then plummeted 85.47% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $465000.0 in 2021, then plummeted by 56.34% to $203000.0 in 2022, then dropped by 29.06% to $144000.0 in 2023, then decreased by 18.75% to $117000.0 in 2024, then tumbled by 85.47% to $17000.0 in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Share-based Compensation are $17000.0 (Q4 2025), $53000.0 (Q3 2025), and $86000.0 (Q2 2025).